國立高雄大學圖資館 |

Language: English

Back

Screening and risk reduction strategies for breast cancerimaging modality and risk-reduction approaches /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Screening and risk reduction strategies for breast canceredited by Masakazu Toi.
Reminder of title:	imaging modality and risk-reduction approaches /
other author:	Toi, Masakazu.
Published:	Singapore :Springer Nature Singapore :2023.
Description:	xii, 189 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	BreastCancer
Online resource:	https://doi.org/10.1007/978-981-19-7630-8
ISBN:	9789811976308$q(electronic bk.)

Screening and risk reduction strategies for breast cancerimaging modality and risk-reduction approaches /
Screening and risk reduction strategies for breast cancerimaging modality and risk-reduction approaches /[electronic resource] :edited by Masakazu Toi. - Singapore :Springer Nature Singapore :2023. - xii, 189 p. :ill., digital ;24 cm.

1. Introduction of the whole issue -- 2. Breast cancer epidemiology: incidence, risks and subtype -- 3. Personalized genetic breast cancer risk estimation with polygenic risk scores -- 4. Mathematical model forassessing breast cancer risk -- 5. Cost-effectiveness Analysis of multigene testing -- 6. Hereditary breast cancer: Its biology, subtype and clinical phenotype -- 7. Surgical risk reduction of breast cancer -- 8. Medical risk reduction of breast cancer -- 9. Screening for breast cancer with mammography -- 10. Breast cancer screening: Weighing the benefits and harms -- 11. Breast cancer screening according to individual risk -- 12. MRI: Detection of noninvasive diseases -- 13. Significance of MRI for women having dense breasts -- 14. Ultrasound: screening of breast cancer -- 15. Detection of breast cancer by PET -- 16. Radiowave mammography -- 17. Photoacoustic imaging of breast cancer.

This book provides readers with the most up-to-date practical information on breast cancer screening. Since breast cancers are highly heterogeneous, time to clinical onset from the initial carcinogenesis differs diversely between cancers. Pathological germline variants and driver mutations cause a high lifetime risk of breast cancer. The lifetime risks are various according to what genes are pathologically dysfunctional. Integrated omics and imaging technologies have established varying tumour characteristics. Thus, this book suggests that a more individualised scheme is required to improve breast cancer screening. A key aim is to demonstrate how multiple diagnostic imaging modalities such as mammography, ultrasonography, MRI, PET and dbPET improve breast cancer screening accuracy. Mammography screening alone may have a limited impact on breast cancer risk prediction. These issues are crucial to discuss. Clinical experts recommend that new modalities be incorporated for women with dense breasts, like ultrasonography, dynamic mammography, MRI and maybe breast-dedicated PET. Topics on these modalities are going to be summarized in this book. An in-depth review of these modalities is summarised in this book. In addition, new diagnostic modalities, including risk assessment tools, multi-cancer early detection tests using liquid biopsy, the role of protein biomarkers in breast cancer risk screening, challenges, and hopes for future advances, are also covered in this book.

ISBN: 9789811976308$q(electronic bk.)

Standard No.: 10.1007/978-981-19-7630-8doiSubjects--Topical Terms:

711508
Breast
--Cancer

LC Class. No.: RC280.B8

Dewey Class. No.: 616.994490754

Screening and risk reduction strategies for breast cancerimaging modality and risk-reduction approaches /
LDR:03479nmm a2200349 a 4500 001 640491
003 DE-He213
005 20230301021841.0
006 m d
007 cr nn 008maaau
008 231025s2023 si s 0 eng d
020 $a 9789811976308$q(electronic bk.)
020 $a 9789811976292$q(paper)
024 7 $a 10.1007/978-981-19-7630-8 $2 doi
035 $a 978-981-19-7630-8
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.B8
072 7 $a MMPH $2 bicssc
072 7 $a MJCL $2 bicssc
072 7 $a SCI058000 $2 bisacsh
072 7 $a MKSH $2 thema
072 7 $a MJCL $2 thema
082 0 4 $a 616.994490754 $2 23
090 $a RC280.B8 $b S433 2023
245 0 0 $a Screening and risk reduction strategies for breast cancer $h [electronic resource] : $b imaging modality and risk-reduction approaches / $c edited by Masakazu Toi.
260 $a Singapore : $b Springer Nature Singapore : $b Imprint: Springer, $c 2023.
300 $a xii, 189 p. : $b ill., digital ; $c 24 cm.
505 0 $a 1. Introduction of the whole issue -- 2. Breast cancer epidemiology: incidence, risks and subtype -- 3. Personalized genetic breast cancer risk estimation with polygenic risk scores -- 4. Mathematical model forassessing breast cancer risk -- 5. Cost-effectiveness Analysis of multigene testing -- 6. Hereditary breast cancer: Its biology, subtype and clinical phenotype -- 7. Surgical risk reduction of breast cancer -- 8. Medical risk reduction of breast cancer -- 9. Screening for breast cancer with mammography -- 10. Breast cancer screening: Weighing the benefits and harms -- 11. Breast cancer screening according to individual risk -- 12. MRI: Detection of noninvasive diseases -- 13. Significance of MRI for women having dense breasts -- 14. Ultrasound: screening of breast cancer -- 15. Detection of breast cancer by PET -- 16. Radiowave mammography -- 17. Photoacoustic imaging of breast cancer.
520 $a This book provides readers with the most up-to-date practical information on breast cancer screening. Since breast cancers are highly heterogeneous, time to clinical onset from the initial carcinogenesis differs diversely between cancers. Pathological germline variants and driver mutations cause a high lifetime risk of breast cancer. The lifetime risks are various according to what genes are pathologically dysfunctional. Integrated omics and imaging technologies have established varying tumour characteristics. Thus, this book suggests that a more individualised scheme is required to improve breast cancer screening. A key aim is to demonstrate how multiple diagnostic imaging modalities such as mammography, ultrasonography, MRI, PET and dbPET improve breast cancer screening accuracy. Mammography screening alone may have a limited impact on breast cancer risk prediction. These issues are crucial to discuss. Clinical experts recommend that new modalities be incorporated for women with dense breasts, like ultrasonography, dynamic mammography, MRI and maybe breast-dedicated PET. Topics on these modalities are going to be summarized in this book. An in-depth review of these modalities is summarised in this book. In addition, new diagnostic modalities, including risk assessment tools, multi-cancer early detection tests using liquid biopsy, the role of protein biomarkers in breast cancer risk screening, challenges, and hopes for future advances, are also covered in this book.
650 0 $a Breast $x Cancer $x Imaging. $3 711508
650 0 $a Breast $x Cancer $x Diagnosis. $3 206250
650 0 $a Breast $x Cancer $x Prevention. $3 486242
650 1 4 $a Radiation Oncology. $3 920157
650 2 4 $a Surgery. $3 274153
650 2 4 $a Clinical Medicine. $3 221285
700 1 $a Toi, Masakazu. $3 748055
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-19-7630-8
950 $a Medicine (SpringerNature-11650)